News | June 06, 2022
Vivimed Labs posts Q4FY22 consolidated loss at Rs. 18.33 Cr
The company has posted net loss of Rs. 67.65 crores for the Financial Year ended March 31, 2022
The company has posted net loss of Rs. 67.65 crores for the Financial Year ended March 31, 2022
To address the preventive & primary healthcare delivery gaps in India
The partnership between Lockwood and Random42 expands the capabilities and geographic footprint for both organizations.
Follows Zealand Pharma’s appointment of Adam Steensberg as CEO and decision to refocus strategy
The new Oncology CRO will aim to drive faster execution and higher quality trial outcomes for Oncology sponsors.
Already an existing partner and supplier of ingredients to Medisca, striking this agreement with SUANFARMA involved reinforcing a well-established symbiotic relationship between two companies committed to world-class quality, service, and price
The company’s annual sales grew from Rs 548.12 crore in FY 2020-21 to Rs 598.65 crore this fiscal
For the third straight year, Lumenis wins an award recognizing outstanding medical companies and technologies
Pfizer calls upon global health leaders and organizations to join the Accord, bringing their expertise and resources to close the health equity gap
The new lab is a testament to the Pondicherry Institute of Medical Sciences (PIMS)’s long-held values and traditions of striving for excellence and embracing newer innovations in order to deliver the best standard of training for their students
Subscribe To Our Newsletter & Stay Updated
